16-81999182-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145168.3(SDR42E1):āc.1111G>Cā(p.Gly371Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145168.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDR42E1 | NM_145168.3 | c.1111G>C | p.Gly371Arg | missense_variant | 3/3 | ENST00000328945.7 | NP_660151.2 | |
SDR42E1 | XM_005256257.5 | c.1111G>C | p.Gly371Arg | missense_variant | 4/4 | XP_005256314.1 | ||
SDR42E1 | XM_011523471.4 | c.1102G>C | p.Gly368Arg | missense_variant | 3/3 | XP_011521773.1 | ||
SDR42E1 | XM_047434925.1 | c.1102G>C | p.Gly368Arg | missense_variant | 3/3 | XP_047290881.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDR42E1 | ENST00000328945.7 | c.1111G>C | p.Gly371Arg | missense_variant | 3/3 | 1 | NM_145168.3 | ENSP00000332407 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000521 AC: 13AN: 249500Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135356
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727246
GnomAD4 genome AF: 0.000414 AC: 63AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.1111G>C (p.G371R) alteration is located in exon 3 (coding exon 2) of the SDR42E1 gene. This alteration results from a G to C substitution at nucleotide position 1111, causing the glycine (G) at amino acid position 371 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at